Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling

Inhibitors of glycogen synthase kinase 3 (GSK3) are being explored as therapy for chronic inflammatory diseases. We previously demonstrated that the GSK inhibitor lithium is beneficial in experimental autoimmune encephalomyelitis (EAE), the mouse model of multiple sclerosis. In this study we report...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowse, Amber L., Naves, Rodrigo, Cashman, Kevin S., McGuire, Donald J., Mbana, Tethia, Raman, Chander, De Sarno, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532311/
https://www.ncbi.nlm.nih.gov/pubmed/23285134
http://dx.doi.org/10.1371/journal.pone.0052658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532311/
https://www.ncbi.nlm.nih.gov/pubmed/23285134
http://dx.doi.org/10.1371/journal.pone.0052658

Ejemplares similares